A low-background fluorescence biosensor was developed for the detection of adenosine triphosphate (ATP) making use of terminal protection from exonuclease I, and exonuclease III-catalyzed target recycling amplification.
No takes yet. Share an insight, caveat, or question.
Li et al. (2014) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: